Detalhe da pesquisa
1.
Bone marrow plasma cells require P2RX4 to sense extracellular ATP.
Nature
; 626(8001): 1102-1107, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355795
2.
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Blood
; 143(2): 139-151, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616575
3.
Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.
Br J Haematol
; 168(3): 371-83, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25284154
4.
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma.
Hematol Oncol Clin North Am
; 38(2): 383-406, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158242
5.
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice.
JCI Insight
; 9(10)2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713510
6.
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.
bioRxiv
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328086
7.
Visual Diagnosis: A 7-week-old Boy with Tachypnea and Poor Feeding.
Pediatr Rev
; 38(2): e6-e9, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28148713
8.
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
Oncotarget
; 13: 986-1002, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093297
9.
Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Exp Hematol
; 44(3): 157-60, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802532
10.
Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
Sci Transl Med
; 7(293): 293ra102, 2015 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109102
11.
Synthesis and photoelectrochemical study of vertically aligned silicon nanowire arrays.
Angew Chem Int Ed Engl
; 48(51): 9680-4, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19918828
12.
Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes.
Mol Cancer Ther
; 13(12): 2784-92, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25319394
13.
Does IL-15 have a causative role in large granular lymphocyte leukemia?
Immunotherapy
; 5(3): 231-4, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23444952